5-Aminoimidazole-4-carboxamide-1-β-d-ribofuranoside increases myocardial glucose uptake during reperfusion and induces late pre-conditioning: Potential role of AMP-activated protein kinase

Basic and Clinical Pharmacology and Toxicology

Volumn 105, Issue 1, 2009, Pages 10-16

  Kristiansen, Steen B ^a   Solskov, Lasse ^a   Jessen, Niels ^a   Løfgren, Bo ^a   Schmitz, Ole ^a,b   Nielsen Kudsk, Jens Erik ^a   Nielsen, Torsten T ^a   Bøtker, Hans Erik ^a   Lund, Sten ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EXERCISE; GLUCOSE TRANSPORT; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE OXYGEN CONSUMPTION; HEART MUSCLE REPERFUSION; HEART PROTECTION; ISCHEMIC PRECONDITIONING; ISOLATED HEART; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT RESPONSE; WISTAR RAT;

AMINOIMIDAZOLE CARBOXAMIDE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BLOOD GLUCOSE; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; GLYCOGEN; HEART; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PHYSICAL EXERTION; PROTECTIVE AGENTS; RANDOM ALLOCATION; RATS; RATS, WISTAR; RIBONUCLEOTIDES; VENTRICULAR PRESSURE;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 67651236746     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2009.00402.x     Document Type: Article

References (44)

1. Bolli R. Preconditioning: a paradigm shift in the biology of myocardial ischemia. Am J Physiol Heart Circ Physiol 2007 292 : H19 27.
2. Bolli R. The late phase of preconditioning. Circ Res 2000 87 : 972 83.
3. Hardie DG, Carling D. The AMP-activated protein kinase-fuel gauge of the mammalian cell? Eur J Biochem 1997 246 : 259 73.
4. Hardie DG, Carling D, Carlson M. The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu Rev Biochem 1998 67 : 821 55.
5. Coven DL, Hu X, Cong L, Bergeron R, Shulman GI, Hardie DG et al. Physiological role of AMP-activated protein kinase in the heart: graded activation during exercise. Am J Physiol Endocrinol Metab 2003 285 : E629 36.
6. Hutber CA, Hardie DG, Winder WW. Electrical stimulation inactivates muscle acetyl-CoA carboxylase and increases AMP-activated protein kinase. Am J Physiol 1997 272 : E262 6.
7. Marsin AS, Bertrand L, Rider MH, Deprez J, Beauloye C, Vincent MF et al. Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia. Curr Biol 2000 10 : 1247 55.
8. Russell RR III, Li J, Coven DL, Pypaert M, Zechner C, Palmeri M et al. AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. J Clin Invest 2004 114 : 495 503. (Pubitemid 39572099)
9. Xing Y, Musi N, Fujii N, Zou L, Luptak I, Hirshman MF et al. Glucose metabolism and energy homeostasis in mouse hearts overexpressing dominant negative α2 subunit of AMP-activated protein kinase. J Biol Chem 2003 278 : 28372 7.
10. Sukhodub A, Jovanovic S, Du Q, Budas G, Clelland AK, Shen M et al. AMP-activated protein kinase mediates preconditioning in cardiomyocytes by regulating activity and trafficking of sarcolemmal ATP-sensitive K(+) channels. J Cell Physiol 2007 210 : 224 36.
11. Berlin JA, Colditz GA. A meta-analysis of physical activity in the prevention of coronary heart disease. Am J Epidemiol 1990 132 : 612 28.
12. Oguma Y, Shinoda-Tagawa T. Physical activity decreases cardiovascular disease risk in women: review and meta-analysis. Am J Prev Med 2004 26 : 407 18.
13. Sjol A, Thomsen KK, Schroll M, Andersen LB. Secular trends in acute myocardial infarction in relation to physical activity in the general Danish population. Scand J Med Sci Sports 2003 13 : 224 30.
14. Yamashita N, Hoshida S, Otsu K, Asahi M, Kuzuya T, Hori M. Exercise provides direct biphasic cardioprotection via manganese superoxide dismutase activation. J Exp Med 1999 189 : 1699 706.
15. Corton JM, Gillespie JG, Hawley SA, Hardie DG. 5-aminoimidazole-4- carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells? Eur J Biochem 1995 229 : 558 65.
16. Galinanes M, Mullane KM, Bullough D, Hearse DJ. Acadesine and myocardial protection. Studies of time of administration and dose-response relations in the rat. Circulation 1992 86 : 598 608.
17. Kingma JG Jr., Simard D, Rouleau JR. Timely administration of AICA riboside reduces reperfusion injury in rabbits. Cardiovasc Res 1994 28 : 1003 1007. (Pubitemid 24232554)
18. Merrill GF, Kurth EJ, Hardie DG, Winder WW. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am J Physiol 1997 273 : E1107 12.
19. Russell RR III, Bergeron R, Shulman GI, Young LH. Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR. Am J Physiol 1999 277 : H643 9.
20. Depre C, Vanoverschelde JL, Taegtmeyer H. Glucose for the heart. Circulation 1999 99 : 578 88.
21. Baldwin D, Chandrashekhar Y, McFalls E, Anand I, Liu D, Jaimes D et al. Ischemic preconditioning prior to aortic cross-clamping protects high-energy phosphate levels, glucose uptake, and myocyte contractility. J Surg Res 2002 105 : 153 9.
22. Kristiansen SB, Henning O, Nielsen-Kudsk JE, Botker HE, Nielsen TT. Effects of l-glutamate supplementation mimic effects of fasting in the ischemic heart. APMIS Suppl 2003 117 21.
23. Musi N, Fujii N, Hirshman MF, Ekberg I, Froberg S, Ljungqvist O et al. AMP-activated protein kinase (AMPK) is activated in muscle of subjects with type 2 diabetes during exercise. Diabetes 2001 50 : 921 7.
24. Essig DA. Contractile activity-induced mitochondrial biogenesis in skeletal muscle. Exerc Sport Sci Rev 1996 24 : 289 319. (Pubitemid 126422678)
25. Buhl ES, Jessen N, Schmitz O, Pedersen SB, Pedersen O, Holman GD et al. Chronic treatment with 5-aminoimidazole-4-carboxamide-1-β-d-ribofuranoside increases insulin-stimulated glucose uptake and GLUT4 translocation in rat skeletal muscles in a fiber type-specific manner. Diabetes 2001 50 : 12 7.
26. Botker HE, Randsbaek F, Hansen SB, Thomassen A, Nielsen TT. Superiority of acid extractable glycogen for detection of metabolic changes during myocardial ischaemia. J Mol Cell Cardiol 1995 27 : 1325 32.
27. Katz J, Dunn A. Glucose-2-t as a tracer for glucose metabolism. Biochemistry 1967 6 : 1 5.
28. Taegtmeyer H, Hems R, Krebs HA. Utilization of energy-providing substrates in the isolated working rat heart. Biochem J 1980 186 : 701 11.
29. Athea Y, Viollet B, Mateo P, Rousseau D, Novotova M, Garnier A et al. AMP-activated protein kinase α2 deficiency affects cardiac cardiolipin homeostasis and mitochondrial function. Diabetes 2007 56 : 786 94.
30. Stoppani J, Hildebrandt AL, Sakamoto K, Cameron-Smith D, Goodyear LJ, Neufer PD. AMP-activated protein kinase activates transcription of the UCP3 and HKII genes in rat skeletal muscle. Am J Physiol Endocrinol Metab 2002 283 : E1239 48.
31. Irrcher I, Adhihetty PJ, Joseph AM, Ljubicic V, Hood DA. Regulation of mitochondrial biogenesis in muscle by endurance exercise. Sports Med 2003 33 : 783 93.
32. Winder WW, Holmes BF, Rubink DS, Jensen EB, Chen M, Holloszy JO. Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle. J Appl Physiol 2000 88 : 2219 26.
33. Jeremy RW, Koretsune Y, Marban E, Becker LC. Relation between glycolysis and calcium homeostasis in postischemic myocardium. Circ Res 1992 70 : 1180 90.
34. Mallet RT, Hartman DA, Bunger R. Glucose requirement for postischemic recovery of perfused working heart. Eur J Biochem 1990 188 : 481 93.
35. Nishino Y, Miura T, Miki T, Sakamoto J, Nakamura Y, Ikeda Y et al. Ischemic preconditioning activates AMPK in a PKC-dependent manner and induces GLUT4 up-regulation in the late phase of cardioprotection. Cardiovasc Res 2004 61 : 610 19.
36. Zhao ZQ, Williams MW, Sato H, Hudspeth DA, McGee DS, Vinten-Johansen J et al. Acadesine reduces myocardial infarct size by an adenosine mediated mechanism. Cardiovasc Res 1995 29 : 495 505.
37. Lasley RD, Randhawa MP Jr., Hegge JO, Mentzer RM. Effects of adenosine and acadesine on interstitial nucleosides and myocardial stunning in the pig. Can J Physiol Pharmacol 1999 77 : 259 67.
38. + exchanger in rat hearts-possible contribution to cardioprotection. Pflugers Arch 2006 453 : 147 56.
39. Bowles DK, Farrar RP, Starnes JW. Exercise training improves cardiac function after ischemia in the isolated, working rat heart. Am J Physiol 1992 263 : H804 9.
40. Bowles DK, Starnes JW. Exercise training improves metabolic response after ischemia in isolated working rat heart. J Appl Physiol 1994 76 : 1608 14.
41. Yamashita N, Baxter GF, Yellon DM. Exercise directly enhances myocardial tolerance to ischaemia-reperfusion injury in the rat through a protein kinase C mediated mechanism. Heart 2001 85 : 331 6.
42. Locke M, Tanguay RM, Klabunde RE, Ianuzzo CD. Enhanced postischemic myocardial recovery following exercise induction of HSP 72. Am J Physiol 1995 269 : H320 5.
43. Chen HC, Bandyopadhyay G, Sajan MP, Kanoh Y, Standaert M, Farese RV Jr. et al. Activation of the ERK pathway and atypical protein kinase C isoforms in exercise- and aminoimidazole-4-carboxamide-1-β-d-riboside (AICAR)-stimulated glucose transport. J Biol Chem 2002 277 : 23554 62.
44. Jessen N, Goodyear LJ. Contraction signaling to glucose transport in skeletal muscle. J Appl Physiol 2005 99 : 330 7.